VJHemOnc is committed to improving our service to you

EHA 2019 | Implications of apoptotic MSCs inducing PG-E2

VJHemOnc is committed to improving our service to you

Francesco Dazzi

Francesco Dazzi, MD, PhD, King’s College London, London, UK, explains that the therapeutic effect of the mesenchymal stromal cells (MSCs) includes reprogramming monocytes to release the prostaglandin PG-E2. This interview took place at the 24th Congress of the European Hematology Association (EHA) 2019, held in Amsterdam, Netherlands.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter